Claro Advisors LLC purchased a new stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) in the fourth quarter, ...

Moody National Bank Trust Division acquired a new stake in Boston Scientific Co. (NYSE:BSX – Free Report) during the 4th ...

Bolt Acquisition Deal Drives BSX Stock Close to 52-Week High Boston Scientific stock is currently trading close to its 52-week high. In the past four trading sessions, the stock has consistently ...

RBC Capital analyst Shagun Singh Chadha maintained a Hold rating on Nevro Corp (NVRO – Research Report) on January 13 and set a price target of ...

Dr. Greg Vigna Spinal cord stimulators are linked to over 80,000 injuries, with lead migration and hematomas causing severe harm <b ...

Truist Financial analyst Richard Newitter maintained a Hold rating on Nevro Corp (NVRO – Research Report) today. The company’s shares closed ...

Since the first brain implant about a year ago, Musk said the company has upgraded the devices with more electrodes, higher ...

A range of spinal cord stimulators have been approved by the FDA, but none specifically for SCI patients. Abbott, Medtronic and Boston Scientific all have products indicated for chronic pain.

CEO Dave Marver to Provide Company Update Wednesday, January 15, 2025 Wednesday, January 15 at 1:30pm Eastern Time (10:30am Pacific Time / 7:30pm Central European Time). The Company presentation and Q ...

Onward Medical today announced the first commercial sales of its ARC-EX spinal cord stimulation system (SCS) in the U.S.